TrialEuropean journal of cancer (Oxford, England : 1990)2025

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial.

Jonathan A Ledermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.